US Stock MarketDetailed Quotes

DSGN Design Therapeutics

Watchlist
  • 4.210
  • +0.020+0.48%
Close Mar 28 16:00 ET
  • 4.210
  • 0.0000.00%
Post 16:02 ET
238.97MMarket Cap-4.78P/E (TTM)

Design Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
26.39%-43.11M
22.96%-9.86M
34.32%-9.55M
18.43%-11.26M
28.61%-12.44M
-14.11%-58.56M
15.19%-12.8M
-4.57%-14.53M
-31.47%-13.8M
-47.32%-17.42M
Net income from continuing operations
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
Depreciation and amortization
10.99%596K
7.97%149K
11.68%153K
13.53%151K
10.85%143K
32.27%537K
11.29%138K
26.85%137K
44.57%133K
57.32%129K
Other non cash items
-81.82%6K
-160.00%-3K
-87.50%1K
-60.00%4K
-60.00%4K
-48.44%33K
-54.55%5K
-42.86%8K
-60.00%10K
-28.57%10K
Change In working capital
-236.40%-993K
181.13%1.61M
519.25%1.68M
-136.75%-1.35M
-430.56%-2.93M
-63.45%728K
-3,053.97%-1.99M
-131.52%-400K
101.21%3.67M
46.67%-553K
-Change in prepaid assets
-88.55%226K
-26.49%605K
203.29%660K
-205.02%-628K
-134.48%-411K
158.18%1.97M
274.73%823K
66.40%-639K
175.58%598K
196.36%1.19M
-Change in payables and accrued expense
2.17%-1.22M
135.84%1.01M
325.52%1.02M
-123.45%-720K
-44.58%-2.52M
-123.14%-1.25M
-788.73%-2.81M
-92.46%239K
91.16%3.07M
-972.50%-1.75M
Cash from discontinued investing activities
Operating cash flow
26.39%-43.11M
22.96%-9.86M
34.32%-9.55M
18.43%-11.26M
28.61%-12.44M
-14.11%-58.56M
15.19%-12.8M
-4.57%-14.53M
-31.47%-13.8M
-47.32%-17.42M
Investing cash flow
Cash flow from continuing investing activities
-16.33%43.96M
-67.02%1.83M
-138.16%-5.83M
128.12%27.33M
4.47%20.62M
123.77%52.54M
626.04%5.56M
124.08%15.27M
107.63%11.98M
4,666.43%19.73M
Net PPE purchase and sale
-32.81%-340K
--0
130.19%16K
-80.90%-161K
-124.14%-195K
72.11%-256K
90.63%-27K
82.90%-53K
63.52%-89K
-14.47%-87K
Net investment purchase and sale
-16.10%44.3M
-67.18%1.83M
-138.14%-5.84M
127.77%27.49M
5.00%20.81M
123.98%52.79M
826.82%5.58M
124.29%15.32M
107.70%12.07M
3,944.90%19.82M
Cash from discontinued investing activities
Investing cash flow
-16.33%43.96M
-67.02%1.83M
-138.16%-5.83M
128.12%27.33M
4.47%20.62M
123.77%52.54M
626.04%5.56M
124.08%15.27M
107.63%11.98M
4,666.43%19.73M
Financing cash flow
Cash flow from continuing financing activities
-29.14%513K
-47.50%263K
-92.31%1K
9.05%229K
20K
208.09%724K
285.38%501K
-91.39%13K
203.96%210K
0
Proceeds from stock option exercised by employees
-29.14%513K
-47.50%263K
-92.31%1K
9.05%229K
--20K
9.37%724K
285.38%501K
-91.39%13K
-6.67%210K
--0
Cash from discontinued financing activities
Financing cash flow
-29.14%513K
-47.50%263K
-92.31%1K
9.05%229K
--20K
208.09%724K
285.38%501K
-91.39%13K
203.96%210K
--0
Net cash flow
Beginning cash position
-20.00%21.2M
8.54%30.33M
68.03%45.7M
2.04%29.4M
-20.00%21.2M
-91.12%26.5M
-34.28%27.94M
-77.27%27.2M
-89.97%28.81M
-91.12%26.5M
Current changes in cash
125.72%1.36M
-15.17%-7.77M
-2,163.22%-15.37M
1,111.29%16.3M
255.00%8.2M
98.05%-5.3M
57.91%-6.74M
100.97%745K
99.04%-1.61M
120.51%2.31M
End cash Position
6.43%22.56M
6.43%22.56M
8.54%30.33M
68.03%45.7M
2.04%29.4M
-20.00%21.2M
-20.00%21.2M
-34.28%27.94M
-77.27%27.2M
-89.97%28.81M
Free cash flow
26.13%-43.45M
23.12%-9.86M
34.67%-9.53M
17.79%-11.42M
27.85%-12.63M
-12.60%-58.82M
16.61%-12.83M
-2.66%-14.59M
-29.31%-13.89M
-47.11%-17.51M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 26.39%-43.11M22.96%-9.86M34.32%-9.55M18.43%-11.26M28.61%-12.44M-14.11%-58.56M15.19%-12.8M-4.57%-14.53M-31.47%-13.8M-47.32%-17.42M
Net income from continuing operations 25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M
Depreciation and amortization 10.99%596K7.97%149K11.68%153K13.53%151K10.85%143K32.27%537K11.29%138K26.85%137K44.57%133K57.32%129K
Other non cash items -81.82%6K-160.00%-3K-87.50%1K-60.00%4K-60.00%4K-48.44%33K-54.55%5K-42.86%8K-60.00%10K-28.57%10K
Change In working capital -236.40%-993K181.13%1.61M519.25%1.68M-136.75%-1.35M-430.56%-2.93M-63.45%728K-3,053.97%-1.99M-131.52%-400K101.21%3.67M46.67%-553K
-Change in prepaid assets -88.55%226K-26.49%605K203.29%660K-205.02%-628K-134.48%-411K158.18%1.97M274.73%823K66.40%-639K175.58%598K196.36%1.19M
-Change in payables and accrued expense 2.17%-1.22M135.84%1.01M325.52%1.02M-123.45%-720K-44.58%-2.52M-123.14%-1.25M-788.73%-2.81M-92.46%239K91.16%3.07M-972.50%-1.75M
Cash from discontinued investing activities
Operating cash flow 26.39%-43.11M22.96%-9.86M34.32%-9.55M18.43%-11.26M28.61%-12.44M-14.11%-58.56M15.19%-12.8M-4.57%-14.53M-31.47%-13.8M-47.32%-17.42M
Investing cash flow
Cash flow from continuing investing activities -16.33%43.96M-67.02%1.83M-138.16%-5.83M128.12%27.33M4.47%20.62M123.77%52.54M626.04%5.56M124.08%15.27M107.63%11.98M4,666.43%19.73M
Net PPE purchase and sale -32.81%-340K--0130.19%16K-80.90%-161K-124.14%-195K72.11%-256K90.63%-27K82.90%-53K63.52%-89K-14.47%-87K
Net investment purchase and sale -16.10%44.3M-67.18%1.83M-138.14%-5.84M127.77%27.49M5.00%20.81M123.98%52.79M826.82%5.58M124.29%15.32M107.70%12.07M3,944.90%19.82M
Cash from discontinued investing activities
Investing cash flow -16.33%43.96M-67.02%1.83M-138.16%-5.83M128.12%27.33M4.47%20.62M123.77%52.54M626.04%5.56M124.08%15.27M107.63%11.98M4,666.43%19.73M
Financing cash flow
Cash flow from continuing financing activities -29.14%513K-47.50%263K-92.31%1K9.05%229K20K208.09%724K285.38%501K-91.39%13K203.96%210K0
Proceeds from stock option exercised by employees -29.14%513K-47.50%263K-92.31%1K9.05%229K--20K9.37%724K285.38%501K-91.39%13K-6.67%210K--0
Cash from discontinued financing activities
Financing cash flow -29.14%513K-47.50%263K-92.31%1K9.05%229K--20K208.09%724K285.38%501K-91.39%13K203.96%210K--0
Net cash flow
Beginning cash position -20.00%21.2M8.54%30.33M68.03%45.7M2.04%29.4M-20.00%21.2M-91.12%26.5M-34.28%27.94M-77.27%27.2M-89.97%28.81M-91.12%26.5M
Current changes in cash 125.72%1.36M-15.17%-7.77M-2,163.22%-15.37M1,111.29%16.3M255.00%8.2M98.05%-5.3M57.91%-6.74M100.97%745K99.04%-1.61M120.51%2.31M
End cash Position 6.43%22.56M6.43%22.56M8.54%30.33M68.03%45.7M2.04%29.4M-20.00%21.2M-20.00%21.2M-34.28%27.94M-77.27%27.2M-89.97%28.81M
Free cash flow 26.13%-43.45M23.12%-9.86M34.67%-9.53M17.79%-11.42M27.85%-12.63M-12.60%-58.82M16.61%-12.83M-2.66%-14.59M-29.31%-13.89M-47.11%-17.51M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
-0.07%
Vale SA
VALE
-1.28%
NVIDIA
NVDA
-1.58%
Ecopetrol
EC
-1.64%
Taylor Morrison Home
TMHC
-2.11%

Unlock the Full List